I’ll be honest with you. I don’t trust pharmaceutical sales reps. Few of them are medical doctors, but they tell doctors which drugs should be prescribed for which patients. Traditionally, their compensation is based in part upon how many drugs the doctors they visit prescribe. This leads to a gigantic incentive to engage in off-label marketing and other unethical practices.
Perhaps this is going to stop at GSK.
Starting next year, bonuses will be determined “in part, by customer feedback, and by a sales professional’s adherence to the company values of transparency, integrity, respect and patient-focus,” the company said earlier this week. (Here’s the Dow Jones Newswires story.)
Source: Bonuses For GSK Pharma Sales Reps Won’t Be Tied to Sales – Health Blog – WSJ
Time will tell.